These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chromatographic resolutions. XIV. Optical resolution of the racemic anticancer drug ifosfamide and other chiral oxazaphosphorines. Blaschke G, Maibaum J. J Chromatogr; 1986 Sep 24; 366():329-34. PubMed ID: 3782324 [Abstract] [Full Text] [Related]
3. Enantiomeric purity determination of acetyl-L-carnitine by NMR with chiral lanthanide shift reagents. Kagawa M, Machida Y, Nishi H, Haginaka J. J Pharm Biomed Anal; 2005 Aug 10; 38(5):918-23. PubMed ID: 16024206 [Abstract] [Full Text] [Related]
4. Determination of enantiomeric purity of nicotine in pharmaceutical preparations by 13C-NMR in the presence of a chiral lanthanide shift reagent. Jaroszewski JW, Olsson A. J Pharm Biomed Anal; 1994 Mar 10; 12(3):295-9. PubMed ID: 8031927 [Abstract] [Full Text] [Related]
6. Determination of enantiomeric purity of tranylcypromine sulfate by proton magnetic resonance spectroscopy with chiral lanthanide shift reagent. Hanna GM, Lau-Cam CA. J Assoc Off Anal Chem; 1989 Mar 10; 72(4):552-5. PubMed ID: 2759984 [Abstract] [Full Text] [Related]
7. Determination of the optical purity and absolute configuration of threo-methylphenidate by proton nuclear magnetic resonance spectroscopy with chiral solvating agent. Hanna GM, Lau-Cam CA. J Pharm Biomed Anal; 1993 Aug 10; 11(8):665-70. PubMed ID: 8257731 [Abstract] [Full Text] [Related]
8. Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine. Salsbury JS, Isbester PK. Magn Reson Chem; 2005 Nov 10; 43(11):910-7. PubMed ID: 16052604 [Abstract] [Full Text] [Related]
9. Optical purity determination, conformer populations and 1H NMR spectral simplification with lanthanide shift reagents--part IX. A method for improved analytical precision for "DOEt", 2,5-dimethoxy-4-ethylamphetamine. Hatzis A, Rothchild R. J Pharm Biomed Anal; 1987 Nov 10; 5(2):119-29. PubMed ID: 16867532 [Abstract] [Full Text] [Related]
10. Determination of the enantiomeric composition of carprofen by proton nuclear magnetic resonance spectroscopy with a chiral lanthanide-shift reagent. Hanna GM, Lau-Cam CA. Talanta; 1989 Sep 10; 36(9):883-7. PubMed ID: 18964827 [Abstract] [Full Text] [Related]
12. Optical purity determination of threo-methylphenidate hydrochloride using a chiral europium nuclear magnetic resonance (NMR) shift reagent. Hanna GM, Lau-Cam CA. Pharm Res; 1990 Jul 10; 7(7):726-9. PubMed ID: 2395800 [Abstract] [Full Text] [Related]
13. Determination of the optical purity of indacrinone by proton nuclear magnetic resonance spectroscopy using chiral lanthanide chelates. Hanna GM, Lau-Cam CA. J Pharm Biomed Anal; 1989 Jul 10; 7(8):919-28. PubMed ID: 2562290 [Abstract] [Full Text] [Related]
14. Direct enantiomeric purity determination of the chiral anesthetic drug bupivacaine by 1H NMR spectroscopy. Hanna GM. Pharmazie; 2001 Apr 10; 56(4):314-7. PubMed ID: 11338671 [Abstract] [Full Text] [Related]
16. A new chiral shift reagent for the determination of enantiomeric excess and absolute configuration in cyanohydrins. Moon LS, Jolly RS, Kasetti Y, Bharatam PV. Chem Commun (Camb); 2009 Mar 07; (9):1067-9. PubMed ID: 19225638 [Abstract] [Full Text] [Related]
17. 1H-NMR studies of drugs with chiral solvating agent: the direct enantiomeric purity determination of the chiral anesthetic, prilocaine. Hanna GM. Enantiomer; 2000 Mar 07; 5(3-4):303-12. PubMed ID: 11126871 [Abstract] [Full Text] [Related]
19. Determination of enantiomeric purity of glycerides with a chiral PMR shift reagent. Bus J, Lok CM, Groenewegen A. Chem Phys Lipids; 1976 Mar 07; 16(2):123-32. PubMed ID: 1269066 [No Abstract] [Full Text] [Related]